1Globe Biomedical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch 1Globe Biomedical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD (NCT05784779) | 1Globe Biomedical Co., Ltd. | 2023-02-28 |
Track 1Globe Biomedical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.